COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
$34.29 0.61 (1.8112%)
Analysed COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) News Sources
Collegium Pharmaceutical, Inc. Q1 2026 Earnings Call Summary
07-05-2026
moby.co
COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results
11-05-2026
yahoo.com
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
12-05-2026
yahoo.com
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
13-05-2026
yahoo.com
Collegium Pharmaceutical's (NASDAQ:COLL) Solid Earnings Are Supported By Other Strong Factors
14-05-2026
yahoo.com
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
17-05-2026
yahoo.com
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions
18-05-2026
yahoo.com
3 Growth Stocks We’re Skeptical Of
26-05-2026
yahoo.com
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Why Collegium Pharmaceutical Inc. (COLL) Stock Is Gaining Attention for Its ADHD Portfolio
27-05-2026
yahoo.com
What is the current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The current price of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is $34.29.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) absolute price change since previous trading day?
The absolute price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is $0.61.
COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) percentage price change since previous trading day?
The percentage price change of COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) since the previous trading day is 1.8112%.
What is the most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent average sentiment score for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)?
The most recent sentiment for COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ) is .
SEC-8K** Filing Available For COLLEGIUM PHARMACEUTICAL INC (COLL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.